Molecular Profiling
191 articles
Molecular Profiling: Getting to Know Your Tumor
Dr. Johanna Bendell explains the value of molecular profiling, which can indicate the best type of chemotherapy for your tumor.
Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments
With stage IV pancreatic cancer, Rick Baker got molecular profiling which helped direct his different treatments, including clinical trials.
The Value of Molecular Profiling and Genetic Testing
Gina Harrison underwent molecular profiling of her pancreatic tumor, which led her to a clinical trial. Genetic testing showed her BRCA1 mutation was random.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Using Molecular Tumor Profiling to Determine the Best Pancreatic Cancer Treatment
A clinical trial looks at whether molecular subtyping of tumors is effective in determining the best pancreatic cancer treatment.
This Versus That: Words to Know
Confused about some of the similar-sounding terms you are hearing during pancreatic cancer treatment? Our list of words to know can help.
Cancer Commons: Democratizing Cancer Care
Do you need a different treatment for your pancreatic cancer? Lola Rahib explains how Cancer Commons Virtual Tumor Board works for patients.
Taking Nothing For Granted
After Whipple surgery and chemoradiation, Susan Zbacnik had molecular profiling, genetic testing, and joined an Immunotherapy clinical trial.
Tweeting About Tumors and How Best to Provide Care
Dr. Michael Pishvaian launches #TumorBoardTuesday, a continuing medical education Twitter chat, to discuss patient treatments for GI cancers.
Genomic Profiling of my Pancreatic Cancer Gave me a New Lease on Life
When standard treatment did not work for Roy Vinke, he had genomic profiling done. A mutation was found, changing his treatment plan.
Precision Medicine from the Get-Go for Pancreatic Cancer
Dr. Ben George and colleagues at the Medical College of Wisconsin are using molecular profiling to determine the best chemotherapy for a patient’s pancreatic cancer.
I Have Pancreatic Cancer; It Does Not Have Me
Bill Shrieves was ready to start a clinical trial for pancreatic cancer when it was found to have spread. He was successfully treated with FOLFIRINOX.
Picking the Right Team
Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.
New Trial to Find Biomarkers to Guide Treatment
Drs. Jennifer Knox and Elizabeth Jaffee lead the PASS-01 trial using biomarkers and other measures to choose individualized treatment.
Chemotherapy to Survive; Fitness to Thrive
Mike Levine switched oncologists to find chemotherapy that works on his pancreatic cancer. After that he was able to compete in the Ironman Triathlon.